by our College Data Analytics TeamPharmacoeconomics/Pharmaceutical Economics is a concentration offered under the pharmacy/pharmaceutical sciences major at Xavier University. We’ve gathered data and other essential information about the master’s degree program in pharmacoeconomics/pharmaceutical economics, such as diversity of students, how many students graduated in recent times, and more.
You can jump to any section of this page using the links below:
Part-time graduates at Xavier paid an average of $670 per credit hour in 2019-2020. This tuition was the same for both in-state and out-of-state students. The average full-time tuition and fees for graduate students are shown in the table below.
| In State | Out of State | |
|---|---|---|
| Tuition | $12,060 | $12,060 |
| Fees | $16 | $16 |
Looking for online learning options? Good news, you can take online classes in the pharmacoeconomics/pharmaceutical economics master’s degree program at Xavier. To see if the school offers distance learning options in other areas, visit the Xavier Online Learning page.
Of the students who received their master’s degree in pharmacoeconomics/pharmaceutical economics in 2019-2020, 50.0% of them were women. This is less than the nationwide number of 57.7%.
Of those graduates who received a master’s degree in pharmacoeconomics/pharmaceutical economics at Xavier in 2019-2020, 62.5% were racial-ethnic minorities*. This is higher than the nationwide number of 19%.
| Race/Ethnicity | Number of Students |
|---|---|
| Asian | 0 |
| Black or African American | 3 |
| Hispanic or Latino | 1 |
| Native American or Alaska Native | 0 |
| Native Hawaiian or Pacific Islander | 0 |
| White | 3 |
| International Students | 0 |
| Other Races/Ethnicities | 1 |
*The racial-ethnic minorities count is calculated by taking the total number of students and subtracting white students, international students, and students whose race/ethnicity was unknown. This number is then divided by the total number of students at the school to obtain the racial-ethnic minorities percentage.
More about our data sources and methodologies.